scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0022-3476(87)80245-7 |
P698 | PubMed publication ID | 2822887 |
P50 | author | Paul Goodyer | Q91685814 |
P2093 | author name string | C R Scriver | |
S Jequier | |||
J B Kronick | |||
T M Reade | |||
P2860 | cites work | Calcification of entheses associated with X-linked hypophosphatemic osteomalacia | Q93559153 |
Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol | Q34629902 | ||
DDAVP test for estimation of renal concentrating capacity in infants and children | Q39542861 | ||
X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization. | Q51655584 | ||
Renal ultrasound in metabolic bone disease | Q68862523 | ||
Phosphate depletion arrests progression of chronic renal failure independent of protein intake | Q69496140 | ||
Observations on the evolution and treatment of idiopathic infantile hypercalcemia | Q70678167 | ||
Long-term treatment of familial hypophosphatemic rickets with oral phosphate and 1α-hydroxyvitamin D3 | Q72899254 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 700-704 | |
P577 | publication date | 1987-11-01 | |
P1433 | published in | The Journal of Pediatrics | Q7743611 |
P1476 | title | Nephrocalcinosis and its relationship to treatment of hereditary rickets | |
P478 | volume | 111 |
Q54301337 | Acute effects of calcitriol and phosphate salts on mineral metabolism in children with hypophosphatemic rickets. |
Q71365069 | Causes of increased renal medullary echogenicity in Turkish children |
Q43639649 | Clinical and etiological profile of refractory rickets from western India |
Q64039348 | Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia |
Q35978987 | Correction of proximal tubule phosphate transport defect in Hyp mice in vivo and in vitro with indomethacin |
Q67913812 | Echogenic renal pyramids in children |
Q90624325 | FGF23 and Associated Disorders of Phosphate Wasting |
Q37958645 | Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment |
Q36360389 | Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications |
Q44310323 | Hypertension in hypophosphatemic rickets--role of secondary hyperparathyroidism |
Q44322863 | Hypophosphataemic rickets: final height and clinical symptoms in adults |
Q46776591 | Hypophosphatemic rickets: results of a long-term follow-up |
Q47449683 | Linear growth in patients with hypophosphatemic vitamin D-resistant rickets: influence of treatment regimen and parental height |
Q67488827 | Metabolic and histologic investigation of the nature of nephrocalcinosis in children with hypophosphatemic rickets and in the Hyp mouse |
Q72343539 | Nephrocalcinosis in X-linked hypophosphatemia: effect of treatment versus disease |
Q24244826 | Recombinant growth hormone therapy for X-linked hypophosphatemia in children |
Q24247886 | Recombinant growth hormone therapy for X-linked hypophosphatemia in children |
Q36487782 | Role of prostaglandins in the pathogenesis of X-linked hypophosphatemia. |
Q40725847 | Therapeutics of X-linked hypophosphatemic rickets |
Q68311448 | Urinary saturation among phosphate-treated children with hypophosphataemic rickets |
Q73146517 | Urinary supersaturation of calcium oxalate and phosphate in patients with X-linked hypophosphatemic rickets and in healthy schoolchildren |
Q30495036 | X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis |
Q39107200 | X-linked hypophosphatemia and growth. |
Q42545654 | X-linked hypophosphatemia: normal renal function despite medullary nephrocalcinosis 25 years after transient vitamin D2-induced renal azotemia |
Search more.